Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VIVUS Inc (NASDAQ:VVUS)

1.50
Delayed Data
As of May 03
 -0.08 / -5.06%
Today’s Change
0.92
Today|||52-Week Range
2.65
+47.06%
Year-to-Date
No recent news for VIVUS Inc.

Today’s Trading

Previous close1.58
Today’s open1.58
Day’s range1.50 - 1.60
Volume659,161
Average volume (3 months)1,084,549
Market cap$164.5M
Dividend yield--
Data as of 3:59pm ET, 05/03/2016

Growth & Valuation

Earnings growth (last year)-12.50%
Earnings growth (this year)+33.47%
Earnings growth (next 5 years)+0.84%
Revenue growth (last year)-16.42%
P/E ratioNM
Price/Sales1.11
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ECYTEndocyte Inc-0.13-3.33%
TKAITokai Pharmaceutical...-0.17-2.34%
--Innovative Pharmaceu...+0.00+2.75%
CARACara Therapeutics In...+0.02+0.33%
Data as of 3:59pm ET, 05/03/2016

Financials

Last reporting dateMay 4, 2016
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$95.4M
Annual profit (last year)-$93.1M
Net profit margin-97.57%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Seth H. Z. Fischer
Chief Financial &
Accounting Officer
Mark K. Oki
Corporate headquarters
Mountain View, California

Forecasts

Partner Offers

Search for Jobs